Cure8 research brief
Patients and clinics are still deciding how much care can be done remotely. Knowing who prefers in-person versus remote visits helps tailor care so patients receive the visit type they need and want, and supports equitable planning of hybrid care models.
Adult IBD patients and caregivers, gastroenterology clinicians and clinic managers, health services researchers, and policymakers planning remote-care services for IBD.
This analysis used responses from patients who previously used an online IBD self-assessment tool and had experience of remote consultations during the early COVID-19 pandemic.
Preference categories were “strong in-person,” “strong remote,” or “no preference,” and associations were examined with regression models across sociodemographic and clinical variables. Key findings reported include that 65% of respondents had no preference, 25% preferred remote care, and 10% preferred in-person care.
Factors associated with in-person preference included older age, male sex, higher area deprivation, Asian ethnicity (vs White), ≥2 comorbidities, Crohn’s disease (vs ulcerative colitis), worse IBD-specific PROs, higher symptom scores, and dissatisfaction with care.
Remote preference was associated with younger age, lower deprivation, fewer comorbidities, ulcerative colitis, better PROs, and greater satisfaction. Home restriction, mobility, and social support were not associated.
How people might use this: The results suggest programs implementing remote IBD care should consider sociodemographic and clinical differences to promote equitable access and avoid unintentionally disadvantaging groups more likely to prefer or need in-person visits.
This entry summarizes the article abstract (structured-content depth: abstract). It is an observational, retrospective survey analysis of patients with prior remote consultation experience during the early COVID-19 pandemic and reports associations (not causal effects). The sample reflects respondents to an online self-assessment tool and may not represent all people with IBD.
Summary confidence: medium.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study quantifies the large NHS and societal costs of Crohn’s disease and ulcerative colitis in the UK and highlights that ongoing management and maintaining remission are major drivers of expense.
The study highlights racial and ethnic disparities in access to IBD care — including specialist visits, use of advanced therapies, and emergency services — which can affect disease management and outcomes. Recognizing...
The article reports that many people with IBD face unaffordable care and medication access problems that can lead to nonadherence and worse health. It offers practical steps to manage costs now and calls for policy...
